Glaucoma News

Ocular hypertension is a risk factor for glaucoma, but in the absence of any glaucomatous damage it does not necessitate medical intervention.

Glaukos and iVeena Delivery Systems have entered into a strategic licensing agreement that grants Glaukos an exclusive global license to develop and commercialize IVMED-80 for the treatment of keratoconus, according to a press release.

Sight Sciences has launched Sion, a bladeless device used to perform goniotomy.

A literature review shed light on the disparities in prevalence, treatment outcomes, adherence to therapy and access to care between persons of African descent and European descent affected by open-angle glaucoma.

Frequent dietary salt intake may increase the risk for glaucoma in patients on antihypertensive therapy, according to a study.

Stand-alone use of the Omni surgical system reduced IOP and the need for IOP-lowering medications at 36 months in adults with open-angle glaucoma, according to a press release from Sight Sciences.

A genetic association study using two-sample Mendelian randomization analysis was able to demonstrate a shared genetic basis and an association between myopic refractive error and the risk for primary open-angle glaucoma.

NEW YORK — Patients from an urban population who presented with advanced neovascular glaucoma had poor outcomes, according to a study.

Nova Eye Medical has established the iTrack Global Data Registry, which will collect prospective data on canaloplasty in the treatment of glaucoma, according to a press release.

Black patients had a higher risk for developing advanced visual field loss after a new diagnosis of primary open-angle glaucoma, according to a study.